Cardiorespiratory effects induced by 2-nitrate-1,3-dibuthoxypropan are reduced by nitric oxide scavenger in rats

Autonomic Neuroscience: Basic and Clinical

Volumn 181, Issue 1, 2014, Pages 31-36

  Queiroz, Thyago M ^a   Mendes Júnior, LeÔnidas G ^a   Guimarães, Drielle D ^a   França Silva, Maria S ^a   Nalivaiko, Eugene ^b   Braga, Valdir A ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Arterial pressure; Nitric oxide; Organic nitrate; Respiratory rate

Indexed keywords

ARTERIAL PRESSURE; NITRIC OXIDE; ORGANIC NITRATE; RESPIRATORY RATE;

ANIMALS; ARTERIAL PRESSURE; BRADYCARDIA; CARDIOVASCULAR AGENTS; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYDROXOCOBALAMIN; HYPOTENSION; MALE; NITRATES; NITRIC OXIDE; NITROGLYCERIN; PROPANE; RATS; RATS, WISTAR; RESPIRATION; TACHYPNEA; VASODILATOR AGENTS;

EID: 84893906910     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.12.012     Document Type: Article

References (44)

1. Alpert J.S. Nitrate therapy in the elderly. Am. J. Cardiol. 1990, 65:23-27.
2. Araújo A.V., Pereira A.C., Grando M.D., da Silva R.S., Bendhack L.M. The new NO donor Terpy induces similar relaxation in mesenteric resistance arteries of renal hypertensive and normotensive rats. Nitric Oxide 2013, 35:47-53.
3. Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. 1977, 74:3203-3207.
4. Bates J.N., Baker M.T., Guerra-Junior R., Harrison D.G. Nitric Oxide Generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 1991, 42:157-165.
5. Bauer J.A., Nolan T., Fung H.L. Vascular and hemodynamic differences between organic nitrates and nitrites. J. Pharmacol. Exp. Ther. 1997, 280:326-331.
6. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994, 368:850-853.
7. Bonaventura D., Oliveira F.S., Lunardi C.N., Vercesi J.A., da Silva R.S., Bendhack L.M. Characterization of the mechanisms of action and nitric oxide species involved in the relaxation induced by the ruthenium complex. Nitric Oxide 2006, 15:387-394.
8. Botelho-Ono M.S., Pina H.V., Sousa K.H.F., Nunes F.C., Medeiros I.A., Braga V.A. Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats. Auton. Neurosci. 2011, 159:38-44.
9. Brady A.J. Nitric oxide synthase activities in human myocardium. Lancet 1993, 13:341-348.
10. Carnevali L., Sgoifo A., Trombini M., Landgraf R., Neumann I.D., Nalivaiko E. Different patterns of respiration in rat lines selectively bred for high or low anxiety. PLoS ONE 2013, 8:e64519.
11. Chen Z., Zhang J., Stamler J.S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc. Natl. Acad. Sci. 2002, 99:8306-8311.
12. Coleman C.G., Wang G., Park L., Anrather J., Delagrammatikas G.J., Chan J., Zhou J., Iadecola C., Pickel V.M. Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus. J. Neurosci. 2010, 30:12103-12112.
13. França-Silva M.S., Luciano M.N., Ribeiro T.P., Silva J.S., Santos A.F., Franca K.C., Nakao L.S., Athayde-Filho P.F., Braga V.A., Medeiros I.A. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat. Eur. J. Pharmacol. 2012, 690:170-175.
14. França-Silva M.S., Monteiro M.M., Queiroz T.M., Santos A.F., Athayde-Filho P.F., Braga V.A. The new nitric oxide donor 2-nitrate-1,3-dibuthoxypropan alters autonomic function in spontaneously hypertensive rats. Auton. Neurosci. 2012, 171:28-35.
15. Fukuma N., Kato K., Munakata K., Hayashi H., Kato Y., Aisu N., Takahashi H., Mabuchi K., Mizuno K. Baroreflex mechanisms and response to exercise in patients with heart disease. Clin. Physiol. Funct. Imaging 2012, 32:305-309.
16. Granjeiro E.M., Machado B.H. NO in the caudal NTS modulates the increase in respiratory frequency in response to chemoreflex activation in awake rats. Respir. Physiol. Neurobiol. 2009, 166:32-40.
17. Harrison D.G., Bates J.N. The nitrovasodilators. New ideas about old drugs. Circulation 1993, 87:1461-1467.
18. Heard D.J., Nichols W.W., Buss D., Kollias G.V. Comparative cardiopulmonary effects of intramuscularly administered etorphine and carfentanil in goats. Am. J. Vet. Res. 1996, 57:87-96.
19. Horn T., Smith P.M., McLaughlin B.E., Bauce L., Marks G.S., Pittman Q.J., Ferguson A.V. Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am. J. Physiol. 1994, 266:306-313.
20. Ignarro L.I. Nitric Oxide Biology and Pathobiology 2000, Academic Press, San Diego, p. 41. first ed.
21. Ignarro L.J., Napoli C., Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ. Res. 2002, 90:21-28.
22. Kabir M.M., Beig M.I., Baumert M., Trombini M., Mastorci F., Sgoifo A., Walker F.R., Day T.A., Nalivaiko E. Respiratory pattern in awake rats: effects of motor activity and of alerting stimuli. Physiol. Behav. 2010, 101:22-31.
23. Kamendi H., Dergacheva O., Wang X., Huang Z.G., Bouairi E., Gorini C., Mendelowitz D. NO differentially regulates neurotransmission to premotor cardiac vagal neurons in the nucleus ambiguus. Hypertension 2006, 48:1137-1142.
24. Kolo L.L., Westfall T.C., Macarthur H. Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:296-303.
25. Korzycka L., Górska D. Study on organic nitrates, part VIII. Pharmacological activity and nitric oxide generation capacity of nitrate derivatives of piperazine. Pharmacol. Rep. 2005, 57:889-895.
26. Kosmicki M.A. Long-term use of short- and long-acting nitrates in stable angina pectoris. Curr. Clin. Pharmacol. 2009, 4:132-141.
27. Krowicki Z.K., Sharkey K.A., Serron S.C., Nathan N.A., Hornby P.J. Distribution of nitric oxide synthase in rat dorsal vagal complex and effects of microinjection of nitric oxide compounds upon gastric motor function. J. Comp. Neurol. 1997, 377:49-69.
28. Laursen J.B., Mülsch A., Boesgaard S., Mordvintcev P., Trautner S., Gruhn N., Nielsen-Kudsk J.E., Busse R., Aldershvile J. In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide. Circulation 1996, 94:2241-2247.
29. McDonald L.J., Murad F. Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med. 1996, 211:1-6.
30. Miller M.R., Megson I.L. Recent developments in nitric oxide donor drugs. Br. J. Pharmacol. 2007, 151:305-321.
31. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
32. Munhoz F.C., Potje S.R., Pereira A.C., Daruge M.G., da Silva R.S., Bendhack L.M., Antoniali C. Hypotensive and vasorelaxing effects of the new NO-donor [Ru(terpy)(bdq)NO+]3+ in spontaneously hypertensive rats. Nitric Oxide 2012, 26:111-117.
33. Muscará M.N., Wallace J.L. Nitric oxide. V. Therapeutic potential of nitric oxide donors and inhibitors. Am. J. Physiol. 1999, 276:1313-1316.
34. Naseem K.M. The role of nitric oxide in cardiovascular diseases. Mol. Aspects Med. 2005, 26:33-65.
35. Paulo M., Rodrigues G.J., da Silva R.S., Bendhack L.M. A new NO donor failed to release NO and to induce relaxation in the rat basilar artery. Eur. J. Pharm. Sci. 2012, 45:344-350.
36. Queiroz T.M., Mendes-Júnior L.G., França-Silva M.S., Nalivaiko E., Braga V.A. Cardiorespiratory Effects Induced by the New Nitric Donor 2-Nitrate-1,3-Dibuthoxypropan are Reduced by Nitric Oxide Scavenger in Rats. XLVIII Brazilian Physiological Society Meeting 2013, Ribeirão Preto, São Paulo, Brazil.
37. Reddy M.K., Schultz H.D., Zheng H., Patel K.P. Altered nitric oxide mechanism within the paraventricular nucleus contributes to the augmented carotid bodychemoreflex in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:149-157.
38. Santos A.F. Novas Perspectivas da Glicerina-Síntese de Novos Nitratos com Propriedades Farmacológicas e Melhoradores de Cetano 2009, Dissertação (Mestrado)-Universidade Federal da Paraíba, João Pessoa, 116 p.
39. Schubert R., Krien U., Wulfsen I., Schiemann D., Lehmann G., Ulfig N., Veh R.W., Schwarz J.R., Gago H. Nitric oxide donor sodium nitroprusside dilates rat small arteries by activation of inward rectifier potassium channels. Hypertension 2004, 43:891-896.
40. 2+ in intact cardiac myocytes. Circ. Res. 1994, 74:970-978.
41. Shukur A., Rizvi S.B., Whitehead D., Seifalian A., Azzawi M. Altered sensitivity to nitric oxide donors, induced by intravascular infusion of quantum dots, in murine mesenteric arteries. Nanomedicine 2013, 9:532-539.
42. Sun S.Y., Wang W., Zucker I.H., Schultz H.D. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J. Appl. Physiol. 1999, 86:1273-1282.
43. Tinker J.H., Michenfelder J.D. Sodium nitroprusside: pharmacology, toxicology and therapeutics. Anesthesiology 1976, 45:340-354.
44. Zhang K., Patel K.P. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am. J. Physiol. 1998, 275:728-734.